![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 18, 15225-15228, May 3, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the
Received for publication, February 15, 2002, and in revised form, March 11, 2002
Progressive external ophthalmoplegia (PEO) is a
heritable mitochondrial disorder characterized by the accumulation of
multiple point mutations and large deletions in mtDNA. Autosomal
dominant PEO was recently shown to co-segregate with a heterozygous
Y955C mutation in the human gene encoding the sole mitochondrial DNA polymerase, DNA polymerase Disruption of mitochondrial energy metabolism causes mitochondrial
disorders that play a central role in many degenerative diseases,
aging, and cancer. Hundreds of mitochondrial and nuclear gene products
are required for the proper functioning of the mitochondria. Accordingly heritable mitochondrial diseases exhibit both maternal and
Mendelian modes of inheritance with considerable genetic heterogeneity (1-3).
Progressive external ophthalmoplegia
(PEO)1 and mitochondrial
neurogastrointestinal encephalomyopathy belong to a subclass of
autosomal mitochondrial disorders associated with depletion of the
mitochondrial genome and/or the accumulation of mutations and deletions
within mtDNA (1, 4-6). Within the last two years, several nuclear
genes controlling maintenance of mtDNA have been identified at disease
loci, including the genes for adenine nucleotide translocator 1 (ANT1)
at locus 4q34-35 (7), thymidine phosphorylase at locus 22q13.32-qter
(8), a putative mitochondrial helicase (Twinkle) at locus 10q24 (9), an
unidentified gene at locus 3p14-21 (10), and the sole mitochondrial
DNA polymerase (pol Located in the active site of pol We previously cloned and expressed the cDNAs for the catalytic
subunit and the accessory subunit of human pol Enzyme Production--
The His6 affinity-tagged
recombinant catalytic subunit of human DNA polymerase
The Y955C p140 derivative was made with the QuikChange site-
directed mutagenesis kit (Stratagene). The mutagenic primers 5'-CTG
CCC AGC ACC ACA GAT GCG GCC GTA and 5'-TAC GGC CGC ATC TGT GGT GCT GGG
CAG were used to generate Y955C in wild-type and exonuclease-deficient backgrounds in the baculovirus transfer vectors
pHu Polymerase Assays--
Reverse transcriptase activities of the
wild-type and Y955C mutant pol Fidelity Assays--
The accuracy of DNA synthesis by human pol
Amino acid sequence alignments (Fig.
1A) and the active site
structure of T7 DNA polymerase (Fig. 1B) suggest that
Tyr-955 in human pol We previously determined the fidelity of wild-type and
exonuclease-deficient pol
ACCELERATED PUBLICATION
Active Site Mutation in DNA Polymerase
Associated with
Progressive External Ophthalmoplegia Causes Error-prone DNA
Synthesis*
,
,
,
§, and
¶
Laboratory of Molecular Genetics and
§ Laboratory of Structural Biology, NIEHS, National
Institutes of Health, Research Triangle Park, North Carolina
27709
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
(pol
). Since Tyr-955 is a
highly conserved residue critical for nucleotide recognition among
family A DNA polymerases, we analyzed the effects of the Y955C mutation on the kinetics and fidelity of DNA synthesis by the purified human
mutant polymerase in complex with its accessory subunit. The Y955C
enzyme retains a wild-type catalytic rate
(kcat) but suffers a 45-fold decrease in
apparent binding affinity for the incoming nucleoside triphosphate
(Km). The Y955C derivative is 2-fold less accurate
for base pair substitutions than wild-type pol
despite the action
of intrinsic exonucleolytic proofreading. The full mutator effect of
the Y955C substitution was revealed by genetic inactivation of the
exonuclease, and error rates for certain mismatches were elevated by
10-100-fold. The error-prone DNA synthesis observed for the Y955C pol
is consistent with the accumulation of mtDNA mutations in patients
with PEO.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
) at locus 15q22-26 (11). Sequence analysis
through the pol
gene (12) in a Belgian pedigree with dominant PEO
identified a heterozygous A to G mutation at codon 955 (Y955C)
(11).
, Tyr-955 is a highly conserved
residue among a wide variety of DNA polymerases. As a family A DNA
polymerase, pol
is related to Escherichia coli DNA
polymerase I and bacteriophage T7 DNA polymerase, and amino acid
sequence alignments reveal that Tyr-955 in pol
is equivalent to
Tyr-766 in E. coli pol I and Tyr-530 in T7 DNA polymerase
(see Fig. 1A). The three-dimensional structure of T7 DNA
polymerase (13) in a ternary complex with DNA and a nucleoside
triphosphate places this conserved tyrosine residue in close proximity
to the incoming dNTP (see Fig. 1B). Functionally Tyr-530 in
T7 DNA polymerase hydrogen bonds with Glu-480 to form part of the
binding pocket for the incoming dNTP and to help discriminate against
ribonucleotides (13). Substitution of Tyr-766 in E. coli pol
I with serine has only a minor effect on
Km(dNTP), and a slight decrease in
kcat is attributed to a 2.5-fold increase in
Kd(DNA) (14). The fidelity of a Y766F
substitution in the Klenow fragment does not show an appreciable
increase in nucleotide misinsertion; however, substitution with alanine
or serine generates an error-prone DNA polymerase attributable to
decreased stringency for selection of dNTPs (15, 16). Interestingly the
Y766A- and Y766S-substituted enzymes exhibited a 17-fold increase in
deletions between direct repeat sequences (16). These results predict
that the Y955C substitution may lower the catalytic efficiency and/or
the fidelity of human pol
.
(12, 17, 18). We
have also produced a 3' to 5' exonuclease-deficient derivative of pol
to study the fidelity of DNA replication and selection of antiviral
nucleotide analogs by pol
(17, 19, 20). In this report we
investigate the effects of the Y955C mutation in human pol
on the
kinetics and fidelity of DNA replication.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
(p140) and
the exonuclease-deficient form (p140 Exo
) were purified
to homogeneity as described previously (17). The
His6-tagged accessory subunit (p55) was purified to
homogeneity, and the two subunit forms of the polymerase (p140·p55
and p140 Exo
·p55) were reconstituted as described
previously (18).
pVL (17) and Exo
pQVSL11.4 (20), respectively. The
Y955C mutation was verified by complete sequencing of the pol
insert in each vector. Recombinant baculoviruses expressing the
exonuclease-proficient or -deficient forms of Y955C pol
were
selected and amplified, and protein was purified as described
previously (17).
with the accessory subunit were
determined at optimal salt concentration with
poly(rA)·oligo(dT)12-18 as substrate (18). Plots of rate
and dTTP concentration in enzyme-limiting reactions utilizing
poly(rA)·oligo(dT)12-18 were fit with the
Michaelis-Menten equation to obtain apparent kinetic constants.
was measured by copying a single-stranded region of bacteriophage
M13 DNA encoding the
-peptide region of the
-galactosidase gene.
Replication errors were scored by transfection and plating on
chromogenic indicator plates to score plaque colors. The necessary
bacterial strains, bacteriophage M13mp2 derivatives, and all procedures related to fidelity assays have been described elsewhere (19, 21).
Gap-filling reaction mixtures (30 µl) contained 25 mM
HEPES·KOH (pH 7.6), 2 mM dithiothreitol, 1 mM
each of dATP, dCTP, dGTP, and dTTP, 4 mM MgCl2,
50 µg/ml acetylated bovine serum albumin, ~150 ng of gapped
M13mp2 DNA, 0.1 M NaCl, and either 20 ng of p140, 20 ng of
p140 Exo
, 200 ng of p140/Y955C, or 830 ng of
p140/Y955C/Exo
, each reconstituted with 1.3-fold molar
excess of p55 accessory subunit. Reaction products were isolated by
phenol extraction and ethanol precipitation, and closure of the gaps
was confirmed by agarose gel electrophoresis prior to transfection.
Mutation frequencies were calculated as described, and specific
nucleotide changes in mutant DNAs were determined by DNA sequencing
(19).
![]()
RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
is crucial for dNTP binding and fidelity of
nucleotide selection. To study the biochemical properties of the Y955C
variant responsible for PEO, we made the Y955C substitution by
site-directed mutagenesis and overproduced the mutant protein in
baculovirus-infected Sf9 cells. As compared with the wild-type
enzyme in the presence of the accessory subunit, the Y955C pol
exhibited a 4-fold reduction in overall DNA polymerase activity in our
standard DNA polymerase assay (data not shown). Steady state kinetic
analyses (Table I) indicated that the
basis for the reduced activity was a 45-fold increase in the apparent
Km for the incoming dNTP from 2.1 µM
(WT Exo
) to 92 µM (Y955C Exo
)
with no reduction in kcat and only a slight
alteration in Kd(DNA). Thus, the Y955C
polymerase has near wild type catalytic efficiency at higher dNTP
concentrations. Since early estimates (22) suggest nucleotide
triphosphate pools in the mitochondrial matrix are high enough to
support competent replication by this mutant polymerase, the reduced
dNTP binding affinity alone may be inadequate to explain the phenotype
in clinically affected heterozygotes (wild type/Y955C). Therefore, we
tested whether the Y955C mutation was affecting the fidelity of DNA
replication by pol
.

View larger version (26K):
[in a new window]
Fig. 1.
Sequence alignment and nucleotide binding
pocket of family A DNA polymerases. A, amino acid
sequence alignment of motif B in human pol
(Hu pol
),
E. coli pol I (Ec polI), and T7 DNA polymerase
(T7 pol). The position of the conserved Tyr residues is
indicated. B, the nucleotide binding pocket of family A DNA
polymerases as derived from the structure of the T7 DNA polymerase
ternary complex (13). The relative positions of the primer, DNA
template, the incoming ddGTP, and residue Tyr-530 (T7 DNA polymerase)
or the analogous Tyr-955 (human pol
) are indicated.
Effects of Y955C mutation on kinetics of DNA synthesis by pol
with and without the p55 accessory
subunit (19). Pol
is highly accurate due to high nucleotide
selectivity and exonucleolytic proofreading. Indeed genetic
inactivation of the exonuclease activity was needed to reveal the
complete error spectrum of the polymerase function. Also the p55
accessory subunit mildly decreased fidelity by promoting extension of
misinserted nucleotides, and this negative effect may be balanced by
the functional benefit of enhanced processivity conferred by the p55
subunit (18, 19). The accuracy of DNA synthesis by the human Y955C pol
was measured in vitro by copying a single-stranded
region of bacteriophage M13mp2 DNA encoding the
-peptide of the
-galactosidase gene as described previously (21). The first
experiment utilized a sensitive reversion assay that measures eight
different single base substitutions at a TGA codon within
lacZ
. In the absence of proofreading, the Y955C mutation
raised the mutation frequency 42-fold from 13 × 10
5
(WT pol
) to 550 × 10
5 (Y955C pol
). In the
exonuclease-proficient background the mutator effect of the Y955C
mutation was 2-fold (0.33 × 10
5 for WT pol
and
0.72 × 10
5 for Y955C pol
), implying that the
majority of misinsertions produced by the Y955C polymerase are
proofread (Table II). Nevertheless this
2-fold increase in base substitution errors should significantly increase the mutant fraction of the heteroplasmic mtDNA pool during the
preclinical onset period leading to PEO.
Error frequencies of wild-type and Y955C mutant pol
To gauge the broader effects of the Y955C mutation on fidelity of
replication, a substrate bearing a 407-nucleotide mutational target was
utilized to score all 12 possible single base substitutions, each in a
variety of sequence contexts, as well as additions and deletions of 199 different template nucleotides (21). The frequencies of lacZ
mutant plaques generated with and without intrinsic proofreading activity by the wild-type and Y955C forms of pol
in the presence of
the 55-kDa accessory subunit are shown in Table II. Under conditions with active proofreading the Y955C mutation did not significantly change the mutation frequency, indicating that the mutations produced by the Y955C mutant polymerase are proofread by its intrinsic 3'-5'
exonuclease. In the absence of proofreading the Y955C polymerase demonstrated a 7-fold higher mutant frequency as compared with the
wild-type polymerase. Sequencing the DNA from mutant plaques revealed
primarily single base substitution errors with 45% of the mutant
plaques containing more than one mutation. When considering all
mispairs, the average base substitution error rate of the Y955C
polymerase was elevated 10-fold in the exonuclease-deficient background
(Fig. 2). Perhaps the most striking
effect of introducing the Y955C mutation was that the rates of forming
point mutations due to T·dTMP and T·dGMP mispairs increased by
factors of 110 and 81, respectively (Fig. 2). In fact, transition
mutations caused by misinsertion of G opposite a template T represent
60% of all of the base substitution errors observed for Y955C pol
(142 of 235 mutants). Interestingly analysis of point mutations in mtDNA from PEO patients revealed A·T
G·C transitions as the most common mutation (8 of 14 cases listed in the MitoMap data base),
although the autosomal defects responsible for these cases of PEO are
not known.2
|
Pathogenic base substitutions in mtDNA are well documented for
PEO.2 Our in vitro data indicate that pol
makes both +1 and
1 frameshift errors at almost 20% of the base
substitution error rate, although proofreading substantially reduces
the frameshift error rate. The Y955C mutation increases the frameshift
error rate by 4-fold, but base substitution errors remain the primary
replication error catalyzed by Y955C pol
. Clinical tests based on
Southern blots or PCR are designed to detect deletions in mtDNA, and
multiple deletions in mtDNA have become a clinical hallmark of PEO.
Large deletions in mtDNA between direct repeats, such as the 4977-base pair deletion between nucleotides 8470 and 13447, are found in both
dominant and recessive forms of PEO (24, 25). We present a model in
which the enhanced base substitution error rate of Y955C pol
promotes deletions between direct repeats in mtDNA (Fig.
3). This mechanism invokes a misinsertion
event following correct synthesis through a direct repeat sequence.
Failure of the polymerase to proofread the error or to extend the
mismatch favors a slippage event between the direct repeats that
creates a matched DNA terminus at a downstream template sequence (Fig. 3). Large deletions between direct repeats were observed for the analogous Y766S mutation in the Klenow fragment (16), and we propose that a common T·dTMP misinsertion by Y955C pol
(Fig. 2)
initiates the 4977-bp deletion observed in some PEO patients.
|
Mitochondrial disorders marked by depletion, deletion, or base
substitution of mtDNA are most likely caused by defects in nuclear
genes that function to maintain mtDNA. Genetic predisposition to the
accumulation of mtDNA mutations, as in PEO patients with the Y955C
allele, is consistent with the delayed-onset and progressive course of
such degenerative mitochondrial diseases. In addition to our
identification of exonuclease-deficient pol
(19) and Y955C pol
as mutator DNA polymerases, Zassenhaus (26) has demonstrated that
transgenic overexpression of exonuclease-deficient pol
in mice is
associated with cardiomyopathy and results in accumulation of point
mutations, deletions, and large deletions flanked by direct repeats.
Thus, mutations that reduce the fidelity of pol
cause mitochondrial
disease through mutagenic replication of mtDNA. The ability of other
pol
mutations linked with disease (11) to affect the fidelity of
the polymerase has not been tested. Multiple mutations within the
"Twinkle" gene encoding a putative mitochondrial helicase are also
causally linked to dominant PEO with mtDNA deletions (9), and a
dysfunctional replicative helicase (dnaB) has been shown to
enhance deletions in E. coli, possibly by stalling the
replication fork (27). Mutations in the nuclear genes for ANT1 or
thymidine phosphorylase also induce pathogenic mutation of mtDNA (7, 8)
perhaps by unbalancing or reducing the available intramitochondrial
pool of deoxynucleoside triphosphates. Nucleotide pool imbalance is
known to enhance base substitution errors by pol
(28, 29).
Additionally Wallace (23) observed mtDNA rearrangement and increased
production of reactive oxygen species in the mitochondria of
ANT1
/
knockout mice, suggesting pathogenesis results
from enhanced oxidative damage to mtDNA. In summary, we believe that
autosomal mitochondrial disorders exhibiting point mutations,
deletions, and rearrangements have a higher mtDNA mutation rate due to
enhanced damage or compromised mechanisms of mtDNA maintenance, and we predict a general mechanism in which point mutations are an early event
in PEO and other mitochondrial diseases affecting the integrity of mtDNA.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Drs. Katarzyna Bebenek and Farid Kadyrov for critical evaluation of the manuscript.
| |
FOOTNOTES |
|---|
* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ To whom correspondence should be addressed: Laboratory of Molecular Genetics, NIEHS, National Institutes of Health, P.O. Box 12233, Research Triangle Park, NC 27709. Tel.: 919-541-4792; Fax: 919-541-7613; E-mail: copelan1@niehs.nih.gov.
Published, JBC Papers in Press, March 15, 2002, DOI 10.1074/jbc.C200100200
2 MitoMap data base at www.gen.emory.edu/mitomap.html.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: PEO, progressive external ophthalmoplegia; pol, DNA polymerase; ANT1, adenine nucleotide translocator 1; WT, wild type.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Wallace, D. C.
(1999)
Science
283,
1482-1488 |
| 2. |
Van Goethem, G.,
Martin, J. J.,
Lofgren, A.,
Dehaene, I.,
Tack, P.,
Van Zandycke, M.,
Ververken, D.,
Ceuterick, C.,
and Van Broeckhoven, C.
(1997)
Eur. J. Neurol.
4,
476-484 |
| 3. |
Van Goethem, G.,
Lofgren, A.,
Martin, J. J.,
and Van Broeckhoven, C.
(2000)
J. Med. Genet.
37,
547-548 |
| 4. |
Zeviani, M.,
Servidei, S.,
Gellera, C.,
Bertini, E.,
DiMauro, S.,
and DiDonato, S.
(1989)
Nature
339,
309-311[CrossRef][Medline]
[Order article via Infotrieve] |
| 5. |
Wallace, D. C.
(1992)
Annu. Rev. Biochem.
61,
1175-1212[CrossRef][Medline]
[Order article via Infotrieve] |
| 6. |
Hirano, M.,
Marti, R.,
Ferreiro-Barros, C.,
Vila, M. R.,
Tadesse, S.,
Nishigaki, Y.,
Nishino, I.,
and Vu, T. H.
(2001)
Semin. Cell Dev. Biol.
12,
417-427[CrossRef][Medline]
[Order article via Infotrieve] |
| 7. |
Kaukonen, J.,
Juselius, J. K.,
Tiranti, V.,
Kyttala, A.,
Zeviani, M.,
Comi, G. P.,
Keranen, S.,
Peltonen, L.,
and Suomalainen, A.
(2000)
Science
289,
782-785 |
| 8. |
Nishino, I.,
Spinazzola, A.,
and Hirano, M.
(1999)
Science
283,
689-692 |
| 9. |
Spelbrink, J. N., Li, F. Y.,
Tiranti, V.,
Nikali, K.,
Yuan, Q. P.,
Tariq, M.,
Wanrooij, S.,
Garrido, N.,
Comi, G.,
Morandi, L.,
Santoro, L.,
Toscano, A.,
Fabrizi, G. M.,
Somer, H.,
Croxen, R.,
Beeson, D.,
Poulton, J.,
Suomalainen, A.,
Jacobs, H. T.,
Zeviani, M.,
and Larsson, C.
(2001)
Nat. Genet.
28,
223-231[CrossRef][Medline]
[Order article via Infotrieve] |
| 10. |
Kaukonen, J. A.,
Amati, P.,
Suomalainen, A.,
Rotig, A.,
Piscaglia, M. G.,
Salvi, F.,
Weissenbach, J.,
Fratta, G.,
Comi, G.,
Peltonen, L.,
and Zeviani, M.
(1996)
Am. J. Hum. Genet.
58,
763-769[Medline]
[Order article via Infotrieve] |
| 11. |
Van Goethem, G.,
Dermaut, B.,
Lofgren, A.,
Martin, J. J.,
and Van Broeckhoven, C.
(2001)
Nat. Genet.
28,
211-212[CrossRef][Medline]
[Order article via Infotrieve] |
| 12. |
Ropp, P. A.,
and Copeland, W. C.
(1996)
Genomics
36,
449-458[CrossRef][Medline]
[Order article via Infotrieve] |
| 13. |
Doublie, S.,
Tabor, S.,
Long, A. M.,
Richardson, C. C.,
and Ellenberger, T.
(1998)
Nature
391,
251-258[CrossRef][Medline]
[Order article via Infotrieve] |
| 14. |
Polesky, A. H.,
Steitz, T. A.,
Grindley, N. D.,
and Joyce, C. M.
(1990)
J. Biol. Chem.
265,
14579-14591 |
| 15. |
Carroll, S. S.,
Cowart, M.,
and Benkovic, S. J.
(1991)
Biochemistry
30,
804-813[CrossRef][Medline]
[Order article via Infotrieve] |
| 16. |
Bell, J. B.,
Eckert, K. A.,
Joyce, C. M.,
and Kunkel, T. A.
(1997)
J. Biol. Chem.
272,
7345-7351 |
| 17. |
Longley, M. J.,
Ropp, P. A.,
Lim, S. E.,
and Copeland, W. C.
(1998)
Biochemistry
37,
10529-10539[CrossRef][Medline]
[Order article via Infotrieve] |
| 18. |
Lim, S. E.,
Longley, M. J.,
and Copeland, W. C.
(1999)
J. Biol. Chem.
274,
38197-38203 |
| 19. |
Longley, M. J.,
Nguyen, D.,
Kunkel, T. A.,
and Copeland, W. C.
(2001)
J. Biol. Chem.
276,
38555-38562 |
| 20. |
Lim, S. E.,
and Copeland, W. C.
(2001)
J. Biol. Chem.
276,
23616-23623 |
| 21. |
Bebenek, K.,
and Kunkel, T. A.
(1995)
Methods Enzymol.
262,
217-232[Medline]
[Order article via Infotrieve] |
| 22. |
Bestwick, R. K.,
Moffett, G. L.,
and Mathews, C. K.
(1982)
J. Biol. Chem.
257,
9300-9304 |
| 23. |
Esposito, L. A.,
Melov, S.,
Panov, A.,
Cottrell, B. A.,
and Wallace, D. C.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
4820-4825 |
| 24. |
Johns, D. R.,
Rutledge, S. L.,
Stine, O. C.,
and Hurko, O.
(1989)
Proc. Natl. Acad. Sci. U. S. A.
86,
8059-8062 |
| 25. |
Shoffner, J. M.,
Lott, M. T.,
Voljavec, A. S.,
Soueidan, S. A.,
Costigan, D. A.,
and Wallace, D. C.
(1989)
Proc. Natl. Acad. Sci. U. S. A.
86,
7952-7956 |
| 26. |
Zhang, D.,
Mott, J. L.,
Chang, S. W.,
Denniger, G.,
Feng, Z.,
and Zassenhaus, H. P.
(2000)
Genomics
69,
151-161[CrossRef][Medline]
[Order article via Infotrieve] |
| 27. |
Saveson, C. J.,
and Lovett, S. T.
(1997)
Genetics
146,
457-470[Abstract] |
| 28. |
Kunkel, T. A.,
and Soni, A.
(1988)
J. Biol. Chem.
263,
4450-4459 |
| 29. |
Wernette, C. M.,
Conway, M. C.,
and Kaguni, L. S.
(1988)
Biochemistry
27,
6046-6054[CrossRef][Medline]
[Order article via Infotrieve] |
This article has been cited by other articles:
![]() |
A. H. Hakonen, S. Goffart, S. Marjavaara, A. Paetau, H. Cooper, K. Mattila, M. Lampinen, A. Sajantila, T. Lonnqvist, J. N. Spelbrink, et al. Infantile-onset spinocerebellar ataxia and mitochondrial recessive ataxia syndrome are associated with neuronal complex I defect and mtDNA depletion Hum. Mol. Genet., December 1, 2008; 17(23): 3822 - 3835. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. F. Pursell, J. T. McDonald, C. K. Mathews, and T. A. Kunkel Trace amounts of 8-oxo-dGTP in mitochondrial dNTP pools reduce DNA polymerase {gamma} replication fidelity Nucleic Acids Res., April 1, 2008; 36(7): 2174 - 2181. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Graziewicz, R. J. Bienstock, and W. C. Copeland The DNA polymerase {gamma} Y955C disease variant associated with PEO and parkinsonism mediates the incorporation and translesion synthesis opposite 7,8-dihydro-8-oxo-2'-deoxyguanosine Hum. Mol. Genet., November 15, 2007; 16(22): 2729 - 2739. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. R. Lee and K. A. Johnson Fidelity and Processivity of Reverse Transcription by the Human Mitochondrial DNA Polymerase J. Biol. Chem., November 2, 2007; 282(44): 31982 - 31989. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Mathews and S. Song Maintaining precursor pools for mitochondrial DNA replication FASEB J, August 1, 2007; 21(10): 2294 - 2303. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ashley, S. Adams, A. Slama, M. Zeviani, A. Suomalainen, A. L. Andreu, R. K. Naviaux, and J. Poulton Defects in maintenance of mitochondrial DNA are associated with intramitochondrial nucleotide imbalances Hum. Mol. Genet., June 15, 2007; 16(12): 1400 - 1411. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S.L. Chan, M. J. Longley, and W. C. Copeland Modulation of the W748S mutation in DNA polymerase {gamma} by the E1143G polymorphismin mitochondrial disorders Hum. Mol. Genet., December 1, 2006; 15(23): 3473 - 3483. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Baruffini, T. Lodi, C. Dallabona, A. Puglisi, M. Zeviani, and I. Ferrero Genetic and chemical rescue of the Saccharomyces cerevisiae phenotype induced by mitochondrial DNA polymerase mutations associated with progressive external ophthalmoplegia in humans Hum. Mol. Genet., October 1, 2006; 15(19): 2846 - 2855. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Mathews DNA precursor metabolism and genomic stability FASEB J, July 1, 2006; 20(9): 1300 - 1314. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. R. Stuart, J. H. Santos, M. K. Strand, B. Van Houten, and W. C. Copeland Mitochondrial and nuclear DNA defects in Saccharomyces cerevisiae with mutations in DNA polymerase {gamma} associated with progressive external ophthalmoplegia Hum. Mol. Genet., January 15, 2006; 15(2): 363 - 374. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. L. Chan, M. J. Longley, and W. C. Copeland The Common A467T Mutation in the Human Mitochondrial DNA Polymerase (POLG) Compromises Catalytic Efficiency and Interaction with the Accessory Subunit J. Biol. Chem., September 9, 2005; 280(36): 31341 - 31346. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. T. Luoma, N. Luo, W. N. Loscher, C. L. Farr, R. Horvath, J. Wanschitz, S. Kiechl, L. S. Kaguni, and A. Suomalainen Functional defects due to spacer-region mutations of human mitochondrial DNA polymerase in a family with an ataxia-myopathy syndrome Hum. Mol. Genet., July 15, 2005; 14(14): 1907 - 1920. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Song, Z. F. Pursell, W. C. Copeland, M. J. Longley, T. A. Kunkel, and C. K. Mathews DNA precursor asymmetries in mammalian tissue mitochondria and possible contribution to mutagenesis through reduced replication fidelity PNAS, April 5, 2005; 102(14): 4990 - 4995. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Ferrari, E. Lamantea, A. Donati, M. Filosto, E. Briem, F. Carrara, R. Parini, A. Simonati, R. Santer, and M. Zeviani Infantile hepatocerebral syndromes associated with mutations in the mitochondrial DNA polymerase-{gamma}A Brain, April 1, 2005; 128(4): 723 - 731. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zeviani and S. Di Donato Mitochondrial disorders Brain, October 1, 2004; 127(10): 2153 - 2172. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Wanrooij, P. Luoma, G. van Goethem, C. van Broeckhoven, A. Suomalainen, and J. N. Spelbrink Twinkle and POLG defects enhance age-dependent accumulation of mutations in the control region of mtDNA Nucleic Acids Res., June 4, 2004; 32(10): 3053 - 3064. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Nishigaki, R. Marti, and M. Hirano ND5 is a hot-spot for multiple atypical mitochondrial DNA deletions in mitochondrial neurogastrointestinal encephalomyopathy Hum. Mol. Genet., January 1, 2004; 13(1): 91 - 101. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Korhonen, M. Gaspari, and M. Falkenberg TWINKLE Has 5' -> 3' DNA Helicase Activity and Is Specifically Stimulated by Mitochondrial Single-stranded DNA-binding Protein J. Biol. Chem., December 5, 2003; 278(49): 48627 - 48632. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Filosto, M. Mancuso, Y. Nishigaki, J. Pancrudo, Y. Harati, C. Gooch, A. Mankodi, L. Bayne, E. Bonilla, S. Shanske, et al. Clinical and Genetic Heterogeneity in Progressive External Ophthalmoplegia Due to Mutations in Polymerase {gamma} Arch Neurol, September 1, 2003; 60(9): 1279 - 1284. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Strand, G. R. Stuart, M. J. Longley, M. A. Graziewicz, O. C. Dominick, and W. C. Copeland POS5 Gene of Saccharomyces cerevisiae Encodes a Mitochondrial NADH Kinase Required for Stability of Mitochondrial DNA Eukaryot. Cell, August 1, 2003; 2(4): 809 - 820. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ogawa, S. Limsirichaikul, A. Niimi, S. Iwai, S. Yoshida, and M. Suzuki Distinct Function of Conserved Amino Acids in the Fingers of Saccharomyces cerevisiae DNA Polymerase {alpha} J. Biol. Chem., May 23, 2003; 278(21): 19071 - 19078. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Limsirichaikul, M. Ogawa, A. Niimi, S. Iwai, T. Murate, S. Yoshida, and M. Suzuki The Gly-952 Residue of Saccharomyces cerevisiae DNA Polymerase {alpha} Is Important in Discriminating Correct Deoxyribonucleotides from Incorrect Ones J. Biol. Chem., May 23, 2003; 278(21): 19079 - 19086. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Lewis Defective mitochondrial DNA replication and NRTIs: pathophysiological implications in AIDS cardiomyopathy Am J Physiol Heart Circ Physiol, January 1, 2003; 284(1): H1 - H9. [Full Text] [PDF] |
||||
![]() |
L. L. M. Hoopes Error Catastrophe in Mutant Mitochondria Sci. Aging Knowl. Environ., November 13, 2002; 2002(45): vp6 - 6. [Abstract] [Full Text] |
||||
| |||||||